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Abstract.	
	
Atrial	 fibrillation	 is	 a	 common	 rhythm	 disturbance.	 One	 of	 the	 main	
parameters	being	crucial	for	the	choice	of	tactics	of	treatment	and	prevention	of	
complications	is	the	life	quality	of	patients.		
	 The	objective	of	our	study	was	to	evaluate	this	indicator	in	patients	with	
atrial	 fibrillation	 depending	 on	 different	 approaches	 to	 treatment.	 The	 study	
involved	254	patients	with	paroxysmal	and	persistent	forms	of	atrial	fibrillation	
and	42	practically	healthy	persons.	The	main	features	of	anamnesis,	presence	of	
comorbidities,	 aggravating	 risk	 factors	 were	 studied	 as	 well	 as	 a	 survey	 using	
“AFEQT	 Questionnaire”	 was	 conducted.	 When	 studying	 the	 anamnesis	 it	 was	
revealed	that	patients	treated	by	medications	only	(the	first	experimental	group)	
had	 arterial	 hypertension	 as	 a	 main	 presumable	 cause	 of	 atrial	 fibrillation	
(92.4%);	in	one	third	of	cases	different	forms	of	coronary	artery	disease	and	heart	
failure	were	diagnosed	(38.6%	and	33.3%,	respectively).	In	the	fourth	group	(after	
left	 ventricular	 revascularization)	 a	 prevailing	 cause	 of	 atrial	 fibrillation	 was	
coronary	heart	disease	 (100%).	 In	the	second	group	 (after	cardioversion)	as	well	
as	 in	the	third	group	 (after	ablation)	the	 largest	proportion	of	patients	was	also	
diagnosed	with	arterial	hypertension	–	62.0%	and	40.9%,	respectively.	The	mean	
total	AFEQT	 score	among	 the	 control	group	was	82.3±3.1	points.	Patients	of	 the	
first	 group	 scored	 the	 minimum	 value	 among	 interviewed	 patients	 -53.4±4.6	 -	
that	 was	 significantly	 less	 compared	 to	 the	 control	 group,	 р<0.05.	 The	 total	
average	value	of	 the	 third	group	was	significantly	higher	 than	 that	 in	 the	 first	
group,	69.3±4.6	points	against	53.4±4.6	points,	respectively,	р<0.05.	
	 Thus,	 it	 was	 found	 that	 the	 lowest	 life	 quality	 is	 typical	 for	 patients	
treated	with	medications	only.	The	patients	after	ablation	have	the	highest	 life	
quality.	 Left	 ventricle	 revascularization	 slightly	 improves	 life	 quality,	 but	 this	
trend	is	not	statistically	significant.	
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Problem	statement	and	analysis	of	the	recent	research		
Atrial	fibrillation	(AF)	is	one	of	the	most	common	rhythm	disturbances	[11].	The	main	efforts	
of	medical	community	around	the	world	are	aimed	at	preventing	complications	of	the	disease	and	
monitoring	clinical	signs,	however,	 incapacitation	and	reduced	 life	quality	that	often	accompany	
this	disease	are	also	 important	 [7].	The	development	of	a	reliable	tool	for	assessing	the	quality	of	
life	 in	 these	 patients	 would	 allow	 us	 to	 detect	 and	 correct	 the	 abnormalities	 timely.	 Although	
currently	 there	 is	 a	 number	 of	 questionnaires	 and	 scales	 a	 unique	 common	 approach	 to	
assessment	of	 the	 entire	 spectrum	of	patients’	 life,	their	physical	performance	and	mental	well-
being	has	not	developed	yet	[4,	10,	13,	14].	Traditionally,	the	major	efforts	of	clinicians	were	aimed	
at	reducing	morbidity	and	mortality	rates	among	patients	with	AF	[8,	12].	However,	several	studies	
demonstrate	 the	 importance	of	 life	quality	 itself.	And	 the	effectiveness	of	many	medicaments	 is	
increasingly	 considered	 in	 the	 context	of	 the	 impact	not	on	 specific	 symptoms,	but	 life	quality,	
which	is	especially	important	for	elderly	patients	[3,	5,	8,	9]	
The	objective	of	the	research	was	to	study	the	peculiarities	of	 life	quality	 in	patients	with	
atrial	fibrillation.	
	
Material	and	methods	
The	results	of	the	examination	of	254	patients	with	paroxysmal	and	persistent	forms	of	AF	
and	42	practically	healthy	persons	(the	control	group)	were	analyzed.	They	were	divided	into	four	
groups:	Group	I	included	132	persons	treated	with	medications	only;	Group	II	included	50	persons	
who	underwent	cardioversion;	Group	III	consisted	of	22	persons	after	ablation;	Group	IV	comprised	
50	 persons	 after	 LV	 revascularization.	 Patients	 were	 selected	 in	 accordance	 with	 the	 inclusion	
criteria:	patient’s	consent	and	compliance,	availability	of	clinical	and	 instrumental	criteria	for	AF	
according	to	the	protocol	of	medical	care	in	the	specialty	“Cardiology”.	The	exclusion	criteria	were	
chronic	 forms	 of	 AF,	 acute	 coronary	 syndromes,	 inflammatory	 diseases	 of	 the	 endocardium,	
endocrine	disorders,	severe	somatic	pathology,	and	cancer.		
Both	studied	groups	and	the	control	one	were	relevant	for	age	and	sex.	The	main	portion	of	
patients	was	distributed	through	the	age	groups	of	“40-55”	and	“60	and	more”	years.	
The	main	 features	of	anamnesis,	presence	of	comorbidities,	aggravating	risk	 factors	were	
studied	as	well	as	a	survey	using	“AFEQT	Questionnaire”	was	conducted	[2].	The	questionnaire	was	
offered	 to	 fill	 in	 by	 all	 patients	 before	 history	 taking	 and	 assessment	 of	 patients’	 condition.	 It	
consists	of	20	 items.	The	responses	are	scored	 from	1	 to	7	Likert	scale,	where	questions	1-18	are	
formed	as	value	judgments	(1=	“Not	at	all…”	to	7	=	“Extremely...”).	Questions	19-	21	relate	to	patients’	
satisfaction	with	 treatment	and	are	not	 included	 in	HRQoL	score	of	 the	AFEQT	questionnaire.	The	
AFEQT	score	was	calculated	based	on	the	following	formula:	
	
	
	
	
The	subscale	scores	were	computed	similarly	to	the	overall	score.	There	were	3	functional	
subscales:	“Symptoms”	–	questions	1-4,	“Daily	activities”	–	questions5-12	and	“Treatment	concern”	
–	questions	13-18.	Questions	19,	20,	and	21	regarding	the	satisfaction	with	health	care	providers	and	
treatment	 were	 not	 included	 in	 the	 overall	 AFEQT	 score	 and	 were	 calculated	 and	 scored	
independently.	 Overall	 scores	 ranged	 from	 0	 to	 100.	 A	 score	 of	 0	 corresponded	 to	 complete	
disability,	while	a	 score	of	100	corresponded	 to	 the	 lack	of	deterioration	of	quality	of	 life.	When	
assessing	 the	degree	of	 satisfaction	 the	 score	of	 “1”	reflected	 complete	 satisfaction	with	 current	
treatment.	
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The	 scale	 “EHRA”	was	used	 to	 evaluate	 the	 severity	 of	 symptoms.	 Class	 I	 indicated	 the	
absence	of	symptoms;	Class	II	pointed	to	the	presence	of	mild	symptoms	not	affecting	normal	daily	
activities;	 Class	 III	 indicated	 the	 presence	 of	 severe	 symptoms	 affecting	 normal	 daily	 activities;	
Class	IV	pointed	to	the	presence	of	disabling	symptoms	precluding	normal	daily	activities.		
The	significance	of	difference	between	dependent	and	independent	variants	was	evaluated	
using	Student’s	t-test;	 the	difference	was	considered	 reliable	at	p<0.05.	Statistical	analysis	of	 the	
results	was	performed	using	a	standard	software	package	“Statistica	7.0	for	Windows	(“Stat	Soft”,	
USA)	[15].	
	
Results	and	discussion	
Data	analysis	 showed	 that	among	patients	of	 the	 third	and	 fourth	 research	groups	 there	
were	no	people	with	symptoms	that	disabled	daily	activities	 (“EHRA	IV”)	 (Fig.	1).	The	most	people	
of	the	first	group	had	severity	class	“EHRA	III”	(those	with	AF	undergoing	therapy	with	medicines	
only),	21.2	%.	There	were	18.0%	and	8.0%	of	such	cases	among	patients	of	the	second	and	the	fourth	
groups,	respectively.	 In	 the	 third	research	group	 (after	ablation)	 there	were	4.6%	of	such	cases.	 It	
should	 be	 noted	 that	 the	 most	 number	 of	 cases	 with	 absence	 of	 symptoms	 disabling	 the	 daily	
activities	was	detected	 in	the	third	experimental	group,	54.6%.	At	the	same	time,	 in	the	 first	and	
second	research	groups	the	proportion	of	such	patients	was	22.0%	and	20.0%,	respectively.	Thus,	
we	 can	 conclude	 that	 the	 most	 favorable	 course	 of	 arrhythmia	 (in	 terms	 of	 impact	 on	 daily	
activities)	was	observed	in	the	third	group,	the	most	unfavorable	one	was	observed	in	the	first	and	
the	second	groups.		
		
Fig.	1.	Distribution	of	patients	according	to	“EHRA”	scale	
	 	
When	 studying	 the	 anamnesis	 we	 revealed	 the	 following	 patterns.	 The	 main	 probable	
factors	related	to	the	development	and	recurrence	of	arrhythmia	in	each	research	group	included	
several	 diseases	 the	 distribution	 of	 which	 had	 a	 different	 character	 (Fig.	 2).	 Patients	 of	 the	 first	
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group	had	arterial	hypertension	as	a	main	presumable	 cause	of	atrial	 fibrillation	 (92.4%);	 in	one	
third	of	cases	different	 forms	of	coronary	artery	disease	and	heart	 failure	were	diagnosed	 (38.6%	
and	33.3%,	respectively).	 In	 the	 fourth	group	a	prevailing	cause	of	atrial	 fibrillation	was	coronary	
heart	disease	 (100%).	 In	the	second	group	 (after	cardioversion)	as	well	as	 in	the	third	group	 (after	
ablation)	the	 largest	proportion	of	patients	was	also	diagnosed	with	arterial	hypertension	–	62.0%	
and	40.9%,	respectively.	According	to	the	Framingham	heart	study	the	most	frequent	causes	of	AF	
included	chronic	heart	failure,	myocardial	 infarction	and	valvular	heart	disease	 (20%	 in	men	and	
31%	women).	[6]	According	to	the	study	“ALFA”	the	leading	cause	of	AF	was	hypertension	(39.4%).	
CHD	and	myocardial	disease	accounted	for	16.6%	and	15.3%,	respectively	[1].	
	
Fig.	2.	Distribution	of	patients	according	to	probable	leading	causes	of	AF		
	 	
When	 analyzing	 complications	 we	 stated	 that	 cerebral	 blood	 flow	 disorders	 were	 most	 often	
diagnosed	in	the	first	group	(19.7%)	(patients	treated	by	medications	only).	Among	patients	with	AF	
who	underwent	LV	revascularization	(the	fourth	group)	more	than	10	%	had	previous	stroke	or	TIA.	
It	should	be	noted	 that	among	 the	second	 research	group	only	4.0%	of	such	cases	were	detected	
and	 among	 the	 third	 one	 there	 was	 no	 patients	 with	 such	 a	 disease.	 Bleeding	 was	 most	 often	
observed	 in	 patients	 of	 the	 first	 group,	 20.5%.	 Unfortunately,	 there	 was	 no	 data	 whether	 it	 was	
clinically	significant;	however,	it	was	obviously	associated	with	the	use	of	anticoagulants.	No	cases	
of	bleeding	were	reported	for	patients	of	the	third	group.	Single	cases	occurred	in	the	fourth	group.	
One	of	 the	severest	complications	–	pulmonary	thromboembolism	–	occurred	in	13.6%	of	patients	
of	 the	 first	group,	2.0%	and	4.6%	of	patients	of	 the	 second	and	 third	groups,	 respectively.	 It	was	
diagnosed	in	6.0%	of	cases	among	persons	of	the	fourth	group.	
When	analyzing	 the	 impact	of	stress	 factors	 (self-assessment	 from	“0”	to	“10”	points),	we	
found	that	the	significant	impact	of	stress	(“5-7”	points)	was	indicated	by	56.8%	of	patients	of	the	
first	group,	58.0%	of	patients	of	the	second	group	and	50.0%	of	patients	of	the	fourth	groups.	About	
60.0%	 of	 respondents	 of	 the	 third	 group	 assessed	 stress	 as	 moderate	 (“1-4”	 points).	 30.0%	 of	
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respondents	of	the	control	group	reported	the	absence	of	stress.	The	majority	of	the	control	group	
reported	a	moderate	stress	(“1-4”	points).	The	absence	of	stress	was	reported	by	12.9%	of	patients	
of	the	first	group	and	4.0%	of	patients	of	the	second	group;	13.6%	patients	of	the	third	group	and	
6.0%	 of	 patients	 of	 the	 fourth	 group.	 Severe	 stress	 (“7-10”	 points)	 was	 reported	 by	 4.6%	 of	
respondents	of	 the	 third	group,	6.0%	of	patients	of	 the	 fourth	group,	8.3%	of	patients	of	 the	 first	
group	and	14.0%	of	patients	of	the	second	group.	There	were	no	 individuals	with	severe	stress	 in	
the	control	group.	
While	 analyzing	 weekly	 physical	 activity,	 which	 was	 rated	 as	 the	 number	 of	 days	 of	
moderate	physical	activity	a	week	 it	was	 revealed	 the	 following.	 It	 should	be	noted	 that	among	
patients	of	almost	all	groups	persons	with	 low	physical	activity	 (1-2	active	days/week)	prevailed.	
Thus,	 there	 were	 65.9%	 and	 70.0%	 of	 patients	 with	 such	 activity	 in	 the	 first	 and	 fourth	 groups,	
respectively.	More	than	half	of	these	persons	were	present	in	the	second	group	(52.0%).	The	largest	
number	of	patients	with	moderate	weekly	activity	 (active	3-4	days/week)	was	 in	 the	 third	group	
(after	ablation).	
Some	of	these	trends	were	also	confirmed	while	assessing	the	life	quality	(Table	1).	First	of	
all	 it	 is	necessary	 to	note	 that	 there	was	 a	 significant	difference	 in	 the	mean	 total	 score	 of	 the	
questionnaire	between	study	groups.	The	mean	 total	AFEQT	score	among	 the	control	group	was	
82.3±3.1	points.	Patients	of	the	first	group	scored	the	minimum	value	among	interviewed	patients	-
53.4±4.6	-	that	was	significantly	less	compared	to	the	control	group,	р<0.05.	The	total	average	value	
of	 the	 third	 group	 was	 significantly	 higher	 than	 that	 in	 the	 first	 group,	 69.3±4.6	points	against	
53.4±4.6	points,	respectively,	р<0.05.	
	
Table	1	
Distribution	of	patients	with	AF	according	to	“AFEQT”	scores		(M±m).	
Parameters,	
points	
Control	group	
(n=42)	
Research	groups	
(n=254)	
I	
(n=132)	
II	
(n=50)	
III	
(n=22)	
IV	
(n=50)	
	 	 	 	 	 	
Overall	score	 82.3±3.1	 53.4±4.6*	 59.6±4.2*	 69.3±4.6*¶	 56.3±3.9*	
Symptoms	 80.1±3.9	 58.4±4.5	 57.6±3.4*	 77.6±4.8	 62.5±3.6	
Treatment	
concern	
	
-	
	
56.5±3.9	
	
61.3±3.6	
	
72.5±4.2	
	
60.3±4.1	
Daily	activities	 89.3±2.9	 51.3±3.6*	 54.2±3.4*	 63.3±3.4*¶	 57.3±3.3*	
Treatment	
satisfaction	
-	 49.8±4.0	 55.3±3.0	 70.9±3.7¶	 61.2±4.1	
	 	
Notes:	
	
	
1.	the	average	values	for	groups	are	indicated;	
2.	*	-	SD	between	the	control	group	and	research	groups,	р<0.05;	
3.	¶	-	SD	between	the	first	and	other	research	groups,	р<0.05.	
	
When	 considering	 the	 symptoms	 subscale,	 the	 worst	 score	 according	 to	 the	 survey	 was	
typical	for	patients	of	the	first	and	the	second	groups.	The	lowest	rate	of	symptoms	was	observed	
in	persons	of	the	third	group	(after	ablation).	Persons	of	the	fourth	group	(after	LV	revascularization)	
showed	the	intermediate	score	in	the	subscale.	It	should	be	noted	that	the	symptoms	of	arrhythmia	
had	 the	 least	 impact	 on	 daily	 activities	 in	 patients	 of	 the	 third	 group.	 Their	 average	 value	 was	
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63.3±3.4	points.	 In	 the	 first	 group	 and	 the	 second	 group	 these	 value	 were	 51.3±3.6	and	54.2±3.4	
points,	 respectively.	 The	 difference	 in	 the	 data	 between	 the	 first	 and	 the	 third	 groups	 was	
statistically	significant,	р<0.05.		
The	 values	 for	 subscale	 “Treatment	 satisfaction”	were	also	characteristic.	Patients	 of	 the	
first	group	were	 the	 least	satisfied	with	 treatment.	The	maximum	score	 for	 this	subscale	 in	 this	
group	 ranged	 within	 49.8±4.0	points.	Patients	of	 the	second	and	 fourth	 groups	 were	 moderately	
satisfied	with	the	progress	and	results	of	treatment.	Their	values	were	55.3±3.0	and	61.2±4.1	points,	
respectively.	The	best	results	were	specific	for	the	 respondents	of	 the	 third	group	whose	average	
score	in	this	subscale	was	70.9±3.7	points	being	significantly	higher	than	the	value	of	the	first	group,	
р<0.05.	
	
Conclusions		
Thus,	it	was	found	that	the	lowest	life	quality	as	well	as	a	high	incidence	of	complications	
is	 typical	 for	 patients	 treated	 with	 medications	 only.	 Left	 ventricle	 revascularization	 slightly	
improves	life	quality,	but	this	trend	is	not	statistically	significant	and	requires	further	researches.	
These	individuals	have	also	a	high	incidence	of	stroke.	Patients	after	ablation	have	the	highest	life	
quality.	They	are	characterized	by	the	lowest	rate	of	symptoms	and	moderate	physical	activity.	
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